m白术内酯Ⅰ通过TLR4/MyD88通路调控肺癌A549细胞增殖侵袭的研究

doi:10.11904/j.issn.1002-3070.2019.03.007

Abstract

Abstract: Objective The Objective of this study was to investigate the role and molecular mechanism of Atractylenolide Ⅰ in the progression of lung cancer.Methods qRT-qPCR and immunohistochemistry were used to detect the expression of TLR4 and MyD88 at levels of mRNA and protein in lung cancer and adjacent tissues.Transwell and MTT assays were used to detect effects of atractylenolide I(100 μM)on the invasion,migration and proliferation of A549 cells.Western blot was also used to detect the effect of atractylenolide I on the expression of TLR4 and MyD88 proteins.Results The expression of TLR4 and MyD88 at levels of mRNA and protein was highly expressed in lung cancer tissues when compared to adjacent tissues(P＜0.05).Compared with the control group,the invasion ability of A549 cells in the Atractylenolide I group was significantly decreased,and the proliferative activity was inhibited(P＜0.05).Atractylenolide I inhibited the expression of TLR4 and MyD88 protein in A549 cells(P＜0.05).Conclusion Atractylenolide I inhibits the invasion and metastasis of lung cancer A549 cells by inhibiting the TLR4/MyD88 pathway.

Key words: Atratcylenolide I, Lung cancer A549 cells, The TLR4/MyD88 pathway, Proliferation, Invasion

CLC Number:

R734.2

LIU Zhiqiang,CHU Yanjie,LIU Jing,WANG Yanbo. Atractylenolide I regulates proliferation and invasion of lung cancer A549 cells through the TLR4/MyD88 pathway[J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 228-232.

References 1

Hirsch FR,Scagliotti GV,Mulshine JL,et al.Lung cancer:Current therapies and new targeted treatments[J].Lancet,2016,389(10066):299-311.2 Mittal D,Gubin MM,Schreiber RD,et al.New insights into cancer immunoediting and its three component phases-Elimination,equilibrium and escape[J].Curr Opin Immunol,2014,27:16-25.3 Koliaraki V,Chalkidi N,Henriques A,et al.Innate sensing through mesenchymal TLR4/MyD88 signals promotes spontaneous intestinal tumorigenesis[J].Cell Rep,2019,26(3):536-545.4 曲媛媛,徐向英,庄明,等.尼妥珠单抗对肺癌A549细胞系的体外放射增敏效应[J].实用肿瘤学杂志,2016,30(6):497-501.5 Liu Y,Jia Z,Dong L,et al.A randomized pilot study of Atractylenolide I on gastric cancer cachexia patients[J].Evid Based Complement Alternat Med,2008,5(3):337-344.6 Siegel RL,Miller KD,Jemal A.Cancer statistics,2019[J].CA Cancer J Clin,2019,69(1):7-34.7 Pardoll DM.The blockade of immune checkpoints in cancer immunotherapy[J].Nat Rev Cancer,2012,12(4):252-264.8 Dholaria B,Hammond W,Shreders A,et al.Emerging therapeutic agents for lung cancer[J].J Hematol Oncol,2016,9(1):138.9 Ma L,Mao R,Shen K,et al.Atractylenolide I-mediated notch pathway inhibition attenuates gastric cancer stem cell traits[J].Biochem Biophys Res Commun,2014,450(1):353-359.10 Huang HL,Lin TW,Huang YL,et al.Induction of apoptosis and differentiation by atractylenolide-1 isolated from atractylodes macrocephala in human leukemia cells[J].Bioorg Med Chem Lett,2016,26(8):1905-1909.11 Ye Y,Chou GX,Wang H,et al.Effects of sesquiterpenes isolated from largehead atractylodes rhizome on growth,migration,and differentiation of B16 melanoma cells[J].Integr Cancer Ther,2011,10(1):92-100.12 Qian X,Fang Z,Qing T,et al.Repression of PDK1-and LncRNA HOTAIR-mediated EZH2 gene expression contributes to the enhancement of atractylenolide 1 and erlotinib in the inhibition of human lung cancercells[J].Cell Physiol Biochem,2018,49(4):1615-1632.13 Xiao Q,Zheng F,Wu JJ,et al.Activation of ERK and mutual regulation of Stat3 and SP1 contribute to inhibition of PDK1 expression by atractylenolide-1 in human lung cancer cells[J].Cell Physiol Biochem,2017,43(6):2353-2366.14 Rogovskii VS.The linkage between inflammation and immune tolerance:interfering with inflammation in cancer[J].Curr Cancer Drug Targets,2017,17(4):325-332.15 Xiao HC,Shu WL,Kui C.The role of toll-like receptor in inflammation and tumor immunity[J].Front Pharmacol,2018,9:878.16 Zhu XX,Burfeind KG,Michaelis KA,et al.MyD88 signalling is critical in the development of pancreatic cancer cachexia[J].J Cachexia Sarcopenia Muscle,2019,10(2):378-390.17 De Visser KE,Eichten A,Coussens LM.Paradoxical roles of the immune system during cancer development[J].Nature Reviews Cancer,2006,6(1):24-37.18 Baniyash M.TCR zeta-chain downregulation:curtailing an excessive inflammatory immune response[J].Nat Rev Cancer,2004,4(9):675-687.19 Rezvani K,Rouce R,Liu E,et al.Engineering natural killer cells for cancer immunotherapy[J].Mol Ther,2017,25(8):487-497.

[1]	QIN Wen,ZHAO Nannan,HAN Yonghuan,XU Yajun. Expression of ZNF436 in gastric cancer and its effect on the migration and invasion of gastric cancer cells by WNT/β-catenin [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 222-227.
[2]	BAI Xiaobin, HUO Longwei, XIE Wanfu, XU Gaofeng, WANG Maode. Expression of Chk1 in glioblastoma and its association with tumor biological behavior and prognosis survival [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 122-127.
[3]	YUAN Guixia, LI Yan, FENG Wanqi, XIA Xiaojuan, LI Xu. Mechanism of tumor suppressor gene DKK2 inhibiting proliferation of nephroblastoma cells in children [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 14-20.
[4]	LIU Juan, ZHANG Shutian. Advances in research on the mechanism of cyclin-dependent kinase inhibitor 3(CDKN3)in tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 575-578.
[5]	LI Wanzhen, YIN Jun, LI Ping, LIN Xiaohui, ZHANG Guoqian, ZHANG Shuxu. The expression and role of miR-17 in radioresistant cells of non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 391-397.
[6]	CHEN Lin, WANG Enxiang, LIU Qunyou, ZHONG Ying, ZHOU Guoliang, ZHAO Xiyan. CDX2 gene inhibits of colon cancer cell proliferation by NF-κB signaling pathway [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 398-403.
[7]	CHEN Zhaohong,HE Yingying,ZHANG Youcai,LU Dingyu. Effects of SOX7 overexpression on proliferation and other biological characteristics of gallbladder carcinoma GBC-SD cells and its mechanism [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 293-297.
[8]	LI Wenhui, LV Bowen, QIAN Jun, SU Liju, YANG Tongshu, QIAN Jingrong, WANG Jie. Effect of microRNA-150 on proliferation,apoptosis,invasion and metastasis of epithelial ovarian cancer cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 208-213.
[9]	DUAN Yanjun, XU Wei, CHEN Wenjie, WANG Fengjuan. Effects of Wnt pathway inhibitor ETC-159 on proliferation and migration of OSCC cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 103-106.
[10]	WANG Xiaoxiao, HUA Teng, WANG Hongbo. Research progress of estrogen receptor-related receptor γ in tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 87-91.
[11]	MENG Yongsheng. Effect of lycopene on the growth of human osteosarcoma cells and its mechanism [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 506-511.
[12]	WANG Rui ,YU Chenhuan ,FANG Jie. Effects of miR-409-5p on the proliferation and migration of hepatoma HepG2 cell line [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(4): 305-309.
[13]	LIU Qing,YOU Bosen,MA Jingguang,XING Lina. The expression and function of microRNA-30a in bladder cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(4): 310-315.
[14]	HAO Xiaojun,WANG Chuanzhuo,ZHAO Xiangxuan,XIN he,LIU Zhaoyu. Effects of miR-34a on proliferation,migration and invasion of colon cancer SW480 cell and its possible mechanism [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(3): 193-198.
[15]	ZHAO Menglei. Effects of lycopene on the proliferation and apoptosis in human hepatocellular carcinoma HepG2 cells [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(3): 211-216.

Atractylenolide I regulates proliferation and invasion of lung cancer A549 cells through the TLR4/MyD88 pathway

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 1

Related Articles 15

Recommended Articles

Metrics

Comments